Private Wealth Asset Management’s SpringWorks Therapeutics SWTX Stock Holding History

Private Wealth Asset Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-268	Closed	-$12.6K	–	1136
2025 Q2	$12.6K	Hold	268	–	–	﹤0.01%	617
2025 Q1	$11.8K	Buy	+268	New	+$12.3K	﹤0.01%	596

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Private Wealth Asset Management's SWTX Position: Q3 2025 in Review

Private Wealth Asset Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 268 shares — an estimated $12.6K sold.

Private Wealth Asset Management first reported a position in SWTX in Q1 2025 and held it in 2 quarters. The position peaked at $12.6K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Private Wealth Asset Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Private Wealth Asset Management sold 268 SpringWorks Therapeutics shares in Q3 2025, an estimated $12.6K.
Private Wealth Asset Management first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 2 quarters.
Private Wealth Asset Management's SpringWorks Therapeutics position peaked at $12.6K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Private Wealth Asset Management's 13F filing for Q3 2025, filed 3 Nov 2025.